These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 31050611

  • 21. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.
    Myers RP, Tandon P, Ney M, Meeberg G, Faris P, Shaheen AA, Aspinall AI, Burak KW.
    Liver Int; 2014 Sep; 34(8):1176-83. PubMed ID: 24256642
    [Abstract] [Full Text] [Related]

  • 22. Use of rapid Model for End-Stage Liver Disease (MELD) increases for liver transplant registrant prioritization after MELD-Na and Share 35, an evaluation using data from the United Network for Organ Sharing.
    Brock GN, Washburn K, Marvin MR.
    PLoS One; 2019 Sep; 14(10):e0223053. PubMed ID: 31581270
    [Abstract] [Full Text] [Related]

  • 23. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
    Atiemo K, Skaro A, Maddur H, Zhao L, Montag S, VanWagner L, Goel S, Kho A, Ho B, Kang R, Holl JL, Abecassis MM, Levitsky J, Ladner DP.
    Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
    [Abstract] [Full Text] [Related]

  • 24. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J, Kim DG, Lee JY, Lee JG, Joo DJ, Kim SI, Kim MS.
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [Abstract] [Full Text] [Related]

  • 25. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.
    Hernaez R, Liu Y, Kramer JR, Rana A, El-Serag HB, Kanwal F.
    J Hepatol; 2020 Dec; 73(6):1425-1433. PubMed ID: 32531416
    [Abstract] [Full Text] [Related]

  • 26. Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death.
    Mazumder NR, Atiemo K, Daud A, Kho A, Abecassis M, Levitsky J, Ladner DP.
    Transplantation; 2020 Jul; 104(7):1413-1418. PubMed ID: 31644488
    [Abstract] [Full Text] [Related]

  • 27. Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver Transplantation.
    Sundaram V, Jalan R, Wu T, Volk ML, Asrani SK, Klein AS, Wong RJ.
    Gastroenterology; 2019 Apr; 156(5):1381-1391.e3. PubMed ID: 30576643
    [Abstract] [Full Text] [Related]

  • 28. Model for end-stage liver disease exceptions in the context of the French model for end-stage liver disease score-based liver allocation system.
    Francoz C, Belghiti J, Castaing D, Chazouillères O, Duclos-Vallée JC, Duvoux C, Lerut J, Le Treut YP, Moreau R, Mandot A, Pageaux G, Samuel D, Thabut D, Valla D, Durand F.
    Liver Transpl; 2011 Oct; 17(10):1137-51. PubMed ID: 21695771
    [Abstract] [Full Text] [Related]

  • 29. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
    Vitale A, Volk ML, De Feo TM, Burra P, Frigo AC, Ramirez Morales R, De Carlis L, Belli L, Colledan M, Fagiuoli S, Rossi G, Andorno E, Baccarani U, Regalia E, Vivarelli M, Donataccio M, Cillo U, Liver Transplantation North Italy Transplant program (NITp) working group.
    J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
    [Abstract] [Full Text] [Related]

  • 30. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Safwan M, Nwagu U, Collins K, Abouljoud M, Nagai S.
    Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
    [Abstract] [Full Text] [Related]

  • 31. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
    van Vugt JLA, Alferink LJM, Buettner S, Gaspersz MP, Bot D, Darwish Murad S, Feshtali S, van Ooijen PMA, Polak WG, Porte RJ, van Hoek B, van den Berg AP, Metselaar HJ, IJzermans JNM.
    J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
    [Abstract] [Full Text] [Related]

  • 32. Center-related Bias in MELD Scores Within a Liver Transplant UNOS Region: A Call for Standardization.
    Verna EC, Connelly C, Dove LM, Adem P, Babic N, Corsetti J, Faix J, Hayden JA, Lifshitz M, Stotler B, Jin Z, Mohan S, Emond JC, Hod EA, Kratz A.
    Transplantation; 2020 Jul; 104(7):1396-1402. PubMed ID: 31651793
    [Abstract] [Full Text] [Related]

  • 33. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK, DiNorcia J, Ji L, Groshen S, Levitsky J, Sung RS, Kim WR, Andreoni K, Mulligan D, Genyk YS.
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [Abstract] [Full Text] [Related]

  • 34. Testing liver allocation in São Paulo, Brazil: the relationship of model for end-stage liver disease implementation with a reduction in waiting-list mortality.
    Salvalaggio PR, Afonso RC, Pereira LA, Ferraz-Neto BH.
    Transplant Proc; 2012 Oct; 44(8):2283-5. PubMed ID: 23026574
    [Abstract] [Full Text] [Related]

  • 35. The Precise Relationship Between Model for End-Stage Liver Disease and Survival Without a Liver Transplant.
    VanDerwerken DN, Wood NL, Segev DL, Gentry SE.
    Hepatology; 2021 Aug; 74(2):950-960. PubMed ID: 33655565
    [Abstract] [Full Text] [Related]

  • 36. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.
    Starlinger P, Ahn JC, Mullan A, Gyoeri GP, Pereyra D, Alva-Ruiz R, Hackl H, Reiberger T, Trauner M, Santol J, Simbrunner B, Mandorfer M, Berlakovich G, Kamath PS, Heimbach J.
    Hepatology; 2021 Sep; 74(3):1533-1545. PubMed ID: 33786862
    [Abstract] [Full Text] [Related]

  • 37. Development and validation of the Gender-Equity Model for Liver Allocation (GEMA) to prioritise candidates for liver transplantation: a cohort study.
    Rodríguez-Perálvarez ML, Gómez-Orellana AM, Majumdar A, Bailey M, McCaughan GW, Gow P, Guerrero M, Taylor R, Guijo-Rubio D, Hervás-Martínez C, Tsochatzis EA.
    Lancet Gastroenterol Hepatol; 2023 Mar; 8(3):242-252. PubMed ID: 36528041
    [Abstract] [Full Text] [Related]

  • 38. IMPACT OF MELD SODIUM ON LIVER TRANSPLANTATION WAITING LIST.
    Freitas ACT, Rampim AT, Nunes CP, Coelho JCU.
    Arq Bras Cir Dig; 2019 Mar; 32(3):e1460. PubMed ID: 31826087
    [Abstract] [Full Text] [Related]

  • 39. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
    Malamon JS, Kaplan B, Jackson WE, Saben JL, Schold JD, Pomfret EA, Pomposelli JJ.
    Int J Surg; 2023 Sep 01; 109(9):2714-2720. PubMed ID: 37226874
    [Abstract] [Full Text] [Related]

  • 40. A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18.
    Biselli M, Dall'Agata M, Gramenzi A, Gitto S, Liberati C, Brodosi L, Ravaioli M, Gambato M, Montalti R, Pinna AD, Burra P, Gerunda GE, Cillo U, Andreone P, Bernardi M.
    Liver Int; 2015 Jan 01; 35(1):184-91. PubMed ID: 24650058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.